The WACC of Reneo Pharmaceuticals Inc (RPHM) is 6.6%.
| Range | Selected | |
| Cost of equity | 8.10% - 11.10% | 9.60% |
| Tax rate | 26.20% - 27.00% | 26.60% |
| Cost of debt | 5.00% - 5.00% | 5.00% |
| WACC | 5.9% - 7.4% | 6.6% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 0.92 | 1.12 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 8.10% | 11.10% |
| Tax rate | 26.20% | 27.00% |
| Debt/Equity ratio | 1 | 1 |
| Cost of debt | 5.00% | 5.00% |
| After-tax WACC | 5.9% | 7.4% |
| Selected WACC | 6.6% | |